Understanding Neuropathy Features in the Context of Nitrous Oxide Abuse: A Combined Electrophysiological and Metabolic Approach
Open Access
- 14 February 2024
- journal article
- research article
- Published by MDPI AG in Biomedicines
- Vol. 12 (2) , 429
Abstract
Background: The incidence of neurological complications associated with nitrous oxide (N2O) abuse, including N2O-induced myelopathy and neuropathy, has risen in the past decade. N2O-induced neuropathy often presents as a subacute axonal pathology; however, demyelinating patterns mimicking Guillain–Barré syndrome have also been observed. This study explores the metabolic pathophysiology of N2O-induced neuropathy, focusing on the alteration in metabolism to provide a deeper understanding of the biochemical pathways influencing the diverse electrophysiological patterns observed. Methods: We conducted a combined metabolic and electrophysiological exploration of 35 patients who underwent electromyographic exams at our referral center over a three-year period for sensorimotor symptoms linked to recreational N2O use. We collected demographic, clinical, radiological, electrophysiological, and biological data. Patients were categorized into axonal or demyelinating groups based on their electrophysiological patterns, and metabolic parameters were compared. Results: Our cohort predominantly exhibited a length-dependent sensorimotor axonal symmetrical neuropathy affecting the lower limbs. Among the patients, 40% met the demyelinating criteria, with four patients exhibiting conduction blocks. The demyelinating group had a significantly higher peripheral neuropathy disability (PND) score at diagnosis. Elevated homocysteine and methylmalonic acid (MMA) levels were noted in all patients, but these were lower in the demyelinating group. Conclusions: This study highlights the diverse electrophysiological manifestations of N2O-induced neuropathy and underscores the potential role of metabolic parameters as biomarkers to understand its pathophysiology. Lower hyperhomocysteinemia and MMA levels were observed in demyelinating patterns. In this study, we did not observe further improvement, but it is well-known that demyelinating features have a better prognosis related to the further remyelination. These findings contribute to a better understanding of N2O-related neuropathic damage and could guide future therapeutic interventions based on biochemical–neurophysiological stratifications.Keywords
This publication has 18 references indexed in Scilit:
- How to distinguish Guillain‐Barré syndrome from nitrous oxide‐induced neuropathy: A 2‐year, multicentric, retrospective studyEuropean Journal of Neurology, 2023
- Comparison of biomarker for diagnosis of nitrous oxide abuse: challenge of cobalamin metabolic parameters, a retrospective studyJournal of Neurology, 2023
- Nitrous oxide-induced predominantly motor neuropathies: a follow-up studyJournal of Neurology, 2021
- Nitrous oxide‐induced myeloneuropathyEuropean Journal of Neurology, 2021
- The Role of Oxidative Stress in Peripheral NeuropathyJournal of Molecular Neuroscience, 2020
- Clinical and electrodiagnostic characteristics of nitrous oxide-induced neuropathy in TaiwanClinical Neurophysiology, 2016
- Laughing gas abuse is no joke. An overview of the implications for psychiatric practiceClinical Neurology and Neurosurgery, 2013
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- In vitro inactivation of methionine synthase by nitrous oxide.Journal of Biological Chemistry, 1986
- Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 1985